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, an ever-increasing number of T H cell subsets has been described. Historically, T H cell subsets were distinguished on the basis of the cytokines that they secrete following restimulation with antigens; for example, T H 1 cells produce interferon-γ (IFNγ), which is required for the clearance of intracellular pathogens, whereas T H 2 cells produce interleukin-4 (IL-4), IL-5 and IL-13, which mediate the immune response against helminths. As our awareness of the diversity of T H cell subsets increased and distinct subsets were found to express overlapping sets of cytokines, lineage-defining or 'master' transcription factors became important additional determinants for the classification of T H cell subsets. For a long time, T H 1 and T H 2 cells have been widely referred to as stably differentiated cell lineages. However, the recent description of additional CD4 + T cell subsets, such as peripherally derived regulatory T (T Reg ) cells, T follicular helper (T FH ) cells, T H 17 cells, T H 9 cells and T H 22 cells, initiated some reconsideration in the field and focused attention on the plasticity of T H cells [2] [3] [4] [5] . It has now become clear that a complex network of transcription factors, epigenetic changes and post-transcriptional regulators is responsible for the development and the maintenance of the different T H cell subsets and their characteristic gene expression programmes [6] [7] [8] [9] [10] . MicroRNAs (miRNAs) are small (approximately 21 nucleotides in length) endogenously expressed RNAs that regulate gene expression. They are sequentially processed from longer transcripts by the ribonuclease III (RNase III) enzymes Drosha (also known as ribonuclease 3) and Dicer, and they exert their function by guiding the Argonaute (AGO) proteincontaining miRNA-induced silencing complex (miRISC) to specific target mRNAs through complementary base pairing
. The miRISC destabilizes target mRNAs and reduces their translation into proteins 11, 12 
.
Whether an mRNA is targeted by miRISC depends on several factors, including alternative splicing, polyadenosine site usage and interplay with RNA-binding proteins. Moreover, the expression of miRNAs is regulated at several stages during their biogenesis -a process that often involves feedback from their target gene products 13 . Each miRNA has many targets and several mRNAs are subject to regulation by more than one miRNA (BOX 2) . Thus, similarly to transcription factors, miRNAs are integral parts of gene expression networks that determine cell identity and function. Conventional methods for the study of coding genes have been complemented by a large number of miRNAspecific technologies that have improved our ability to measure miRNA expression, to determine their biological functions and to empirically identify their mRNA targets
T helper cells (T H cells). Effector T cells that develop from naive CD4 + T cells. Following their activation, T H cells produce cytokines that regulate cellular and humoral immunity.
MicroRNA-mediated regulation of T helper cell differentiation and plasticity
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Abstract | CD4 + T helper (T H ) cells regulate appropriate cellular and humoral immune responses to a wide range of pathogens and are central to the success of vaccines. However, their dysregulation can cause allergies and autoimmune diseases. The CD4 + T cell population is characterized not only by a range of distinct cell subsets, such as T H 1, T H 2 and T H 17 cells, regulatory T cells and T follicular helper cells -each with specific functions and gene expression programmes -but also by plasticity between the different T H cell subsets. In this Review, we discuss recent advances and emerging ideas about how microRNAs -small endogenously expressed oligonucleotides that modulate gene expression -are involved in the regulatory networks that determine T H cell fate decisions and that regulate their effector functions.
miRNA-induced silencing complex
(miRISC). The microRNAinduced silencing complex consists of a microRNA (miRNA) bound to an Argonaute protein. The miRNA provides sequence specificity for the function of the complex in translational repression and in decreasing target mRNA stability.
As a result of their evolutionarily conserved abundance and wide range of functions, miRNAs are becoming increasingly thought of as an integral part of the cellular machinery that confers overall robustness to biological processes 14 . There is also growing evidence that miRNAs are crucial modulators of development and function in the immune system and that miRNAs regulate important aspects of T H cell differentiation [15] [16] [17] [18] [19] [20] [21] . In this Review, we discuss how miRNAs are important for modulating naive CD4 + T cell maintenance, activation and clonal expansion, as well as how miRNA expression itself is regulated during these processes. In addition, we examine how miRNAs regulate the differentiation of distinct effector T H cell subsets and the lineage-specific effector functions of T H cell subsets, with a focus on T H 1, T H 2, T H 17 and T FH cells. Furthermore, we review the literature that is available about the miRNA-mediated regulation of T Reg cell differentiation and function, and we conclude with a perspective on future challenges and the clinical relevance of miRNA biology.
Regulation of T cell activation by miRNAs
Effector T H cell differentiation is highly influenced by the strength of T cell receptor (TCR) stimulation, the nature of the co-stimulatory molecules expressed on antigenpresenting cells and the cytokine microenvironment 9 . Early systematic miRNA profiling studies in cells of the murine haematopoietic system identified cell typespecific patterns of miRNA expression that suggested an important role for miRNAs in cell lineage specification and effector functions 22 . These findings were corroborated and extended in subsequent miRNA-profiling studies that used small-RNA sequencing or high-throughput quantitative PCR to profile human CD4 + T cells, among many other cell types 23 , naive and in vitro-activated human CD4 + T cells 24 , several human T H cell subsets 25 and a broad range of mouse haematopoietic cell types 26 .
Alterations in miRNA-mediated control following T cell activation. Not surprisingly, T cell-specific deletion of essential factors in the miRNA biogenesis pathway, such as Dicer [27] [28] [29] , Drosha 30 and the microprocessor complex subunit DGCR8 (REF. 31 ), decreased the survival and the proliferation of T cells following activation (FIG. 1a) . However, miRNA-deficient CD4 + T cells also showed a surprising increase in effector T H cell differentiation and cytokine production 27, 30, 32 . The enhanced differentiation of miRNA-deficient T cells indicates that miRNAs are important in the maintenance of the naive T cell state 27, 30, 32 . This raises the question of how T cells overcome the miRNA barrier when they receive signals that induce differentiation.
One possibility is that key mRNAs that are restrained by miRNA-mediated control in naive T cells are transcriptionally induced to such an extent following activation that their repression by miRNAs has an Box 1 | miRNA biogenesis and function MicroRNA (miRNA) genes are transcribed into primary miRNAs (pri-miRNAs) by RNA polymerase II. Pri-miRNAs are bound by the microprocessor complex subunit DGCR8 and processed by the ribonuclease III (RNase III) activity of Drosha into hairpin structures known as precursor miRNAs (pre-miRNAs). Exportin 5 shuttles pre-miRNAs from the nucleus into the cytoplasm where the RNase III Dicer cleaves off the hairpin loop of the pre-miRNA. The resulting duplex segregates and the mature single-stranded miRNA associates with Argonaute (AGO) proteins and other accessory proteins to form the miRNA-induced silencing complex (miRISC), which mediates the translational repression and the increased degradation of its mRNA targets. A mature miRNA bound to an AGO protein forms the core of the miRISC. The AGO protein recruits other protein complexes that antagonize translation and that deadenylate the targeted mRNA 130 . This ultimately leads to mRNA decapping and degradation. Therefore, the effect of miRNA-mediated repression can be observed at both the protein and the mRNA level (see figure) .
The miRNA provides specificity through complementary base pairing with target mRNAs 11 . Nucleotides in positions 2-8 from the 5ʹ end of an miRNA (termed the seed sequence) are a major determinant of target recognition. However, complementarity in the 3ʹ half of the miRNA can contribute to binding and 'seedless' targets that rely on non-seed sequences for binding also occur. Most functional miRNA-binding sites occur in the 3ʹ untranslated region of target mRNAs and many of these are highly conserved, which indicates that miRNAs have co-evolved with their targets. These principles have been exploited to develop algorithms for the bioinformatic prediction of miRNA targets. Although these algorithms are useful for hypothesis generation, they remain imperfect; any predicted targets must be experimentally confirmed and many true targets are missed. Nature Reviews | Immunology 
Positive selection
The process by which immature T cells are selected in the thymus for the expression of a functional T cell receptor.
Negative selection
The process by which immature T cells that have a high affinity for self antigens are deleted in the thymus to prevent the egress of autoreactive T cells into the circulation.
miRNA family
MicroRNAs (miRNAs) are classified into families that share the same seed sequence and are therefore predicted to share many of the same target mRNAs; for example, the polycistronic miR-17~92 cluster comprises six miRNAs representing four separate miRNA families -the miR-17 family (miR-17 and miR-20a), the miR-18 family (miR-18a), the miR-19 family (miR-19a and miR-19b) and the miR-25 family (miR-92a).
insignificant effect. However, at least two other contributing mechanisms have been discovered. mRNAs with shortened 3ʹ untranslated regions (UTRs) and, thus, fewer miRNA-binding sites are produced through alternative polyadenylation in proliferating T cells 33 . In addition, T cell activation induces the ubiquitylation of AGO2 and its proteasome-dependent degradation, which decreases the half-life of AGO2 to less than 2 hours 32 . This results in a global reduction in miRNA abundance and also rapidly remodels the miRNA repertoire to promote the expression of a few miRNAs that are transcriptionally upregulated following T cell activation.
Among the miRNAs that are substantially downregulated after T cell activation, some, such as miR-29, inhibit the differentiation of particular T H cell subsets 31, 34, 35 ; others, such as miR-125, seem to inhibit effector T cell differentiation in general. miR-125b is highly expressed in human naive CD4 + T cells compared with various memory T cell populations, and it inhibits the expression of several genes that are involved in T cell differentiation, including IFNG, IL2RB, IL10RA and PRDM1 (which encodes the transcriptional repressor B lymphocyte-induced maturation protein 1 (BLIMP1)) 25 (FIG. 1b) . Interestingly, miR-125b is not highly expressed in mouse CD4 + T cells 25 . Instead, the closely related miR-125a is highly expressed in naive mouse T cells and rapidly downregulated following their activation 32 . In addition, of the miR-125b target genes that have been identified in human T cells, only the PRDM1 mRNA has the predicted miR-125-binding site in mice 25 . This indicates that attention needs to be given to species-specific differences, as the miRNomes of human and mouse lymphocytes and their target mRNAs are not completely conserved, which is possibly due to evolutionary pressures from pathogens.
miRNA-mediated regulation of TCR signalling. During their development in the thymus, T cells undergo positive selection and negative selection. In the periphery, the activation of mature naive T cells that encounter foreign antigens leads to clonal selection and differentiation into effector T cells. In all of these thymic and peripheral processes, the sensitivity of a TCR to recognize cognate peptides has important implications for the fate of the T cell. It is not surprising that the signalling cascade downstream of TCR activation is highly regulated at multiple levels, and several miRNAs have been shown to be important in this regulation (FIG. 1b) .
The miR-181 miRNA family is one such regulator of TCR signalling that has clear effects on T cell development and homeostasis. The inhibition of miR-181 in thymocytes decreases TCR sensitivity and impairs positive and negative selection in the thymus 36 . Conversely, the overexpression of miR-181a in mature T cells increases their sensitivity to peptide antigens in the periphery 36 . miR-181a targets multiple phosphatases that decrease TCR signals, including SH2 domaincontaining protein tyrosine phosphatase 2 (Shp2; also known as Ptpn11), protein tyrosine phosphatase nonreceptor type 22 (Ptpn22), dual-specificity protein phosphatase 5 (Dusp5) and Dusp6, thereby reducing the TCR engagement threshold for cellular responses 36 (FIG. 1b) . As a consequence, an endogenous peptide that positively selects T cells in the thymus but that fails to activate specific T cell responses in the periphery can become a self antigen when T cells develop in the absence of miR-181a activity 37 . The miR-181 family consists of four unique mature miRNAs encoded in three miRNA clusters; one of these clusters, miR-181a1b1, is particularly important in T cells. Three independent studies have identified defects in thymocyte development in miR-181a1b1-deficient mice [38] [39] [40] . Natural killer T (NKT) cell development is particularly dependent on miR-181 (REFS 38, 40) . Providing an agonistic TCR ligand 40 or eliminating the miR-181 target phosphatase and tensin homologue (Pten) 38 rescued the defective NKT cell development in miR-181a1b1-deficient mice. This indicates that miR-181 has an important role in regulating phosphoinositide 3-kinase (PI3K) signalling downstream of TCR activation. In addition to its effect on TCR signalling, miR-181 targets Notch-regulated ankyrin repeat protein (Nrarp) and decreases the Notch signals that are important for thymocyte development 39 . A lack of miR-181a1b1 also compromises peripheral T cell homeostasis and TCR signalling 38, 39 . Naturally occurring changes in miR-181 expression have been implicated in the age-associated decline in CD4 + T cell immunity. A decreased level of expression of miR-181a
Box 2 | Regulation of gene expression networks by miRNAs
The magnitude of repression of direct microRNA (miRNA) targets is fairly low: less than 50% at both the protein and the mRNA level in the majority of cases. Nevertheless, miRNAs can have marked effects on biological processes (see figure) . Target genes are frequently inhibited by a combination of several miRNAs (see figure; where miRNAs X, Y and Z represent different miRNAs). Similarly, each miRNA targets many genes at the same time (see figure; where mRNAs 1, 2 and 3 represent different mRNAs). In some cases, the effects of miRNAs are amplified through the coordinated repression of several target mRNAs in a common pathway. Small changes in individual targets can also have big effects in systems that are controlled by feedback mechanisms and activation thresholds. In this context, miRNAs can be important to maintain effective gene silencing in the context of 'leaky' transcription that produces a functionally significant amount of mRNA in an inappropriate cell type or biological condition. Finally, the combined effect of miRNAs that repress many target genes can buffer transient or uncoordinated transcription events, thereby setting thresholds for signals that induce programmed changes in gene expression, such as those that mediate T helper cell differentiation and plasticity. miRISC, microRNA-induced silencing complex. 
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Seed recognition sequences
Sequences on mRNA targets that are recognized by the seed sequence of a microRNA; that is, by the nucleotides in positions 2-8 of the microRNA 5ʹ end.
with age is associated with increased DUSP6 expression and decreased TCR sensitivity 41 . Neonatal CD4 + T cells were found to express more miR-181a than adult peripheral blood CD4 + T cells, and miR-181a expression occurred at the same time as increased activation-induced calcium influx and extracellular signalregulated kinase (ERK) phosphorylation. However, neonatal cells have a separate defect in activator protein 1 (AP-1)-dependent transcription, which ultimately results in impaired T cell activation 42 . Taken together, these data indicate that the regulation of miR-181a expression might influence age-dependent changes in T cell responsiveness, but that additional mechanisms have a dominant influence in certain contexts, such as in the case of human neonates. miR-146a is an important feedback regulator of nuclear factor-κB (NF-κB) signalling (FIG. 1b) . It is abundantly expressed in human memory T cells and its expression is further induced by NF-κB p50 (also known as NFKB1) following TCR engagement [43] [44] [45] . In turn, miR-146a targets TNF receptor-associated factor 6 (Traf6) and IL-1 receptor-associated kinase 1 (Irak1), which provides a negative feedback loop that controls the intensity and the duration of NF-κB signalling 46 . The absence of this feedback loop causes spontaneous myeloproliferation and myeloid cell tumorigenesis in miR-146a-deficient mice 45 . miR-146a deficiency in T cells causes hyper-responsiveness to TCR signals and unresolved T cell-mediated inflammation 46 . Together with its role in T Reg cells (discussed below), these effects make miR-146a a powerful inhibitor of autoimmunity.
miRNA-mediated control of T cell proliferation and survival. The miR-17~92 cluster comprises six miRNAs from four miRNA families that regulate several aspects of T cell activation as well as the subsequent fate of the activated T cells. This miRNA cluster and the related miR-106a~363 and miR-106b~25 clusters are all expressed in CD4 + and CD8 + T cells 32, 47 . The overexpression of miR-17~92 in T cells causes lymphoproliferation and an autoimmune-like disease that is characterized by increased serum antibody levels and an increased production of autoantibodies 48 . Both miR-17 and miR-92 family miRNAs can enhance T cell proliferation in the absence of other miRNAs 31 . Another miR-17~92 cluster member, miR-19, positively regulates the survival of activated T cells. These miRNAs mediate their effects through many direct target genes, including Pten and the pro-apoptotic BCL-2-interacting mediator of cell death (Bim; also known as Bcl2l11) 48, 49 (FIG. 1b) .
PI3K signalling and the downstream regulators of metabolic activity are subject to high levels of control by miRNAs in T cells. Pten is a common target of several miRNA families that are differentially expressed during T cell development and activation, including miR-17, miR-19, miR-181 and miR-21 (REFS 38, 48, 50) . Another phosphatidylinositol phosphatase, SH2 domaincontaining inositol polyphosphate 5ʹ phosphatase 1 (Ship1; also known as phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1), is a validated direct target of miR-155 (REFS 49, 51) , which is the miRNA that is most highly induced by TCR stimulation 32, 52, 53 . miR-155 deficiency decreases T cell-dependent humoral and cellular immune responses, probably as a result of the absence of its activity on several mRNA targets [53] [54] [55] [56] . Transcriptomewide biochemical analysis of AGO2-binding sites in mRNAs from activated primary mouse T cells identified more than 300 sites containing miR-155 seed recognition sequences, and almost 200 miR-155-dependent sites, including a large percentage (approximately 40%) that lacked canonical miR-155 seed recognition sequences 49 . Thus, the regulation of T cell behaviour by miR-155, and therefore by miRNAs in general, involves a large network of co-regulated target mRNAs.
Box 3 | Methods for studying miRNAs and their function
There are several methods to profile and to quantify microRNA (miRNA) expression in cells, tissues and body fluids. These range from measuring single miRNAs by conventional or multiplexed quantitative PCR in purified T cell subsets, to the genome-wide analysis of miRNA expression by microarrays and RNA sequencing 75, 131 . Online databases list miRNA sequences and annotations 132 and both bioinformatically predicted 133 and experimentally validated 134 miRNA targets. The function of miRNAs can be studied using various gain-of-function and loss-of-function technologies. The conditional deletion of key molecules of the miRNA biogenesis pathway showed that miRNAs regulate many aspects of CD4 + T cell behaviour, but the current challenge is to understand how each miRNA contributes to these effects. Two consortia have generated freely available miRNA-deficient embryonic stem cells 135 and conditional knockout mice 136 that will be very helpful in advancing our understanding of miRNA functions in vivo. Specific inhibition of miRNAs can also be achieved using a variety of transfectable or self-deliverable synthetic antagonists (also known as antagomirs), or by overexpressing target mRNA sequences that function as sponges for miRNAs, thereby decreasing their activity against endogenous targets 137 . The overexpression of specific miRNAs can be achieved using transfectable synthetic miRNA mimics, expression constructs, viral vectors or transgenesis in mice.
Understanding the mechanism of miRNA function requires methods to identify their targets 138 . Genome-wide transcriptional profiling of specific miRNA-deficient or miRNA-overexpressing cells and control cells can be used to assess global target gene expression changes; however, it is often difficult to distinguish direct and indirect targets using this approach. Direct targets can be validated using 3ʹ untranslated region luciferase reporter assays, yet validating the functional relevance of these targets requires genetic rescue experiments. Biochemical techniques, such as high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation (HITS-CLIP) 139 and photoactivatableribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) 140 , have recently been developed to identify RNA sequences that bind to RNA-binding proteins such as Argonaute proteins. Nature Reviews | Immunology + T cells results in increased and aberrant cytokine production and decreased cell proliferation (right panel). b | A mechanistic overview of the participation of miRNAs in regulatory networks that control T cell activation, the expansion of the T cell population and effector T cell differentiation is shown. The T cell receptor (TCR) signalling cascade activates nuclear factor of activated T cells (NFAT) and nuclear factor-κB (NF-κB), both of which induce the upregulation of miR-155 expression. miR-155 targets SH2 domain-containing inositol polyphosphate 5ʹ phosphatase 1 (Ship1) and suppressor of cytokine signalling 1 (Socs1), and promotes T cell activation and population expansion. NF-κB signalling also induces the expression of miR-146a, which inhibits T cell activation and population expansion through a negative feedback loop involving the miR-146a target genes TNF receptor-associated factor 6 (Traf6) and interleukin-1 receptor-associated kinase 1 (Irak1). Mammalian target of rapamycin (mTOR) signalling results in accelerated miRNA turnover and promotes T cell survival and proliferation partly through MYC-induced miR-17~92 expression. The high levels of expression of miR-125b in human naive CD4 + T cells impede T cell differentiation by repressing T cell effector genes, including interferon-γ (IFNG), IL2RB and PRDM1 (the gene encoding B lymphocyte-induced maturation protein 1 (BLIMP1)). The downregulation of inhibitory phosphatases such as dual-specificity protein phosphatase 5 (Dusp5), Dusp6, protein tyrosine phosphatase non-receptor type 22 (Ptpn22) and SH2 domain-containing protein tyrosine phosphatase 2 (Shp2) by miR-181a increases TCR signalling. IL-2-induced miR-182 expression interferes with T cell population expansion by targeting the transcription factor forkhead box protein O1 (Foxo1). It is worth noting that specific miRNAs are both regulated targets and upstream regulators of signalling pathways that control T cell behaviour. AGO2, Argonaute 2; Bim, BCL-2-interacting mediator of cell death; DC, dendritic cell; Pten, phosphatase and tensin homologue. 
miRNA mimics
Small transfectable synthetic RNAs that mimic endogenous microRNAs; they are used to study the effects of microRNA overexpression.
IL-2 is an important regulator of CD4
+ T cell metabolism and proliferation 57 . It is produced by activated T cells and can function in an autocrine manner. miR-146a has been suggested to be a negative regulator of IL-2 production in activated human CD4 + T cells 44 , and miR-9 has been described as a positive regulator of IL-2 production, possibly through the direct targeting of PRDM1 (REFS 58, 59) , which is a known repressor of Il2 transcription 60 . In addition, miR-182 enhances clonal selection downstream of IL-2 receptor signalling by inhibiting forkhead box protein O1 (FOXO1), which is a transcription factor that is highly expressed in naive T cells and that limits T cell proliferation 61 . Early during T cell stimulation, FOXO1 is inactivated by phosphorylation downstream of TCR signalling. However, later in the response IL-2 that is produced by activated T cells induces miR-182, which represses Foxo1 at the post-transcriptional level (FIG. 1b) .
In summary, miRNAs can have powerful effects on biological processes by regulating genes that control signalling thresholds. Several miRNAs function at multiple levels to regulate the development, the homeostasis and the activation of T cells. These effects have important consequences for T cell function, and they are complemented by the miRNA-mediated regulation of particular T cell differentiation pathways and effector mechanisms.
Regulation of effector T H cells by miRNAs
It is increasingly recognized that miRNAs are important modulators of T H cell fate decisions and effector functions. Their fine-tuning activity is particularly well suited to their function early in the response when small changes in the expression of key genes can have a big effect on cell fate. In addition, miRNAs can regulate the plasticity and the effector functions of differentiated T H cell subsets. + T cell-expressed miRNAs, miR-29a and miR-29b are the most potent inhibitors of T H 1 cell differentiation and IFNγ expression 31 . miR-29 is highly expressed in naive T cells and it inhibits T H 1 cell differentiation through multiple direct targets (FIG. 2) . Tbx21 is one such target in CD4 + T cells, but miR-29 also targets the closely related transcription factor eomesodermin (Eomes), which is usually not expressed in CD4 + T cells 31 . EOMES regulates IFNγ production in natural killer (NK) cells and CD8 + T cells, and, in the absence of miRNAs, it is also inappropriately expressed in CD4 + T cells and contributes to their aberrant IFNγ expression 31 . miR-29 can also directly target the Ifng mRNA 35 . Transgenic mice expressing a miRNA sponge that reduces miR-29a-mediated control have higher serum IFNγ levels and more effective clearance of the intracellular bacterium Listeria monocytogenes 35 . A recent study confirmed the importance of miR-29 in restraining IFNγ expression by T cells using mice in which the mir-29ab1 gene cluster had been knocked out 34 . Several other miRNAs regulate T H 1 cell differentiation and function (FIG. 2) . miR-146a-deficient CD4 62 . By contrast, miR-155 enhances both T H 1 and T H 17 cell-dependent tissue inflammation 55 . Among its many identified targets in T cells 49 , miR-155 inhibits suppressor of cytokine signalling 1 (Socs1) and Ship1 (REFS 51, 63) , which are negative regulators of cytokine signalling. In addition, miR-155 targets Ifngr1 mRNA and might be responsible for the downregulation of the IFNγ receptor in activated CD4 + T cells that differentiate into T H 1 cells 52 . Epistasis experiments showed that miR-155 deficiency is dominant over miR-146 deficiency, as cells lacking both miRNAs are as defective in IFNγ expression and antitumour immunity as those only lacking only miR-155 (REF. 51 ).
The miR-17~92 cluster also affects T H 1 cell differentiation. CD4 + T cells freshly isolated from the peripheral lymph nodes of 10-12 month old mice that expressed a transgene encoding the human miR-17~92 cluster showed a marked increase in the frequency of IFNγ-expressing cells 48 . Similarly, naive miR-17~92-transgenic CD4 + T cells produced larger amounts of IFNγ under T H 1 cell-polarizing conditions in vitro 48 . Conversely, the T cell-specific deletion of the miR-17~92 cluster in mice resulted in a gene dose-dependent reduction of IFNγ-secreting CD4 + T cells 64 . The reconstitution of CD4 + T cells lacking the miR-17~92 cluster with individual miRNA mimics identified miR-19b as being sufficient to restore IFNγ production 64 . T H 1 cell differentiation can be indirectly influenced by miRNAs targeting genes in immune cells other than CD4 + T cells; for example, miR-21 regulates T H 1 cell differentiation by modulating IL-12 production by dendritic cells (DCs) (FIG. 2) . IL-12 is an important cytokine that induces T-bet and IFNγ expression and that supports the proliferation and the survival of T H 1 cells 65 . miR-21 is highly expressed in DCs and directly targets the mRNA that encodes IL-12p35 (REF. 66 ). miR-21 deficiency increases IL-12 expression in DCs and enhances T H 1 cell development and delayed-type hypersensitivity responses in vivo 67 . It is possible that other miRNAs that modulate DC activity and cytokine production also have important indirect effects on T H cell differentiation and function. Nature Reviews | Immunology 
Locked nucleic acid
(LNA). An RNA oligonucleotide bearing a modification of the ribose moiety in its backbone that 'locks' it in a favourable conformation for base pairing, which increases its binding affinity. LNAs are used in various applications for microRNA detection and in microRNA inhibitors for experimental and therapeutic use.
Studies of T H 1 cell differentiation and function have provided insights into the T cell-intrinsic and T cellextrinsic roles of miRNAs in T cell differentiation and
have enabled us to model the general mechanisms of miRNA-mediated regulation of cell differentiation. Some of the miRNAs that regulate T H 1 cells have identical or related roles in other IFNγ-producing lymphocytes, such as cytotoxic CD8 + T cells and NK cells 68, 69 . We expect that the lessons learned through the study of T H 1 cells will continue to increase our broader understanding of miRNA-mediated regulation of the immune system. 70 , and dysregulated T H 2 cell responses cause allergies and asthma 71 . Over the past few decades, much progress has been made in our understanding of the molecular requirements for the generation of T H 2 cells. Differentiation systems in vitro and, more recently, elegant in vivo approaches have established the importance of a positive feedback loop, involving the hallmark T H 2 cell-associated cytokine IL-4 and the transcription factors STAT6 and GATA-binding protein 3 (GATA3), in the amplification of T H 2 cell responses; however, the initial signals that lead to T H 2 cell differentiation have been harder to define 72 . In addition to IL-4, T H 2 cells express the genetically linked cytokines IL-5 and IL-13, which drive type 2 inflammation through their effects on myeloid and non-haematopoietic cells 7 . Compared with T H 1 cells, the miRNA-mediated regulation of T H 2 cell differentiation is poorly understood. Overexpression of miR-21 in T cells increases T H 2 cell differentiation in vitro 73 , whereas overexpression of miR-27 or miR-128 decreases the secretion of IL-4 and IL-5 by activated CD4 + T cells 74 . Further work is needed to characterize the importance of these miRNAs in T H 2 cell responses. In addition, miR-155-deficient T cells show a slight bias towards T H 2 cell differentiation in vitro. This is accompanied by the dysregulation of many target genes, including Maf, which encodes a transcription factor (which is also known as cMAF) that regulates IL-4 production 53, 54 . Approximately 50% of ageing miR-155-deficient mice develop spontaneous lung inflammation that has some, but not all, of the hallmarks of type 2 inflammation that have been associated with asthma 54 . This pathology might be caused by cell-intrinsic defects in T H 2 cell differentiation, but it might also reflect other changes in T cell responses or requirements for miR-155 in other cells.
T H 2 cell differentiation. T H 2 cells regulate immune responses against helminths
The accessibility of the lungs for local drug delivery makes asthma an attractive disease candidate for miRNA-directed therapies. miRNA expression patterns that are associated with asthma have been detected in both lung epithelial cells and purified T cells from human asthmatic subjects 75, 76 . In addition, several proof-of-concept studies have shown that miRNA inhibitors can be protective in mouse models of allergic asthma. Challenge of mice with house dust mite (HDM) allergen increases miR-126 expression in the airway wall, and intranasal administration of a miR-126-specific antagomir (which is a cholesterol-linked single-stranded RNA that is complementary to miR-126) decreases airway hyper-responsiveness and eosinophil recruitment to the lungs 77 . Treatment with the miR-126-specific antagomir was also shown to reduce lung eosinophilia in a mouse model of chronic asthma but it did not have sustained effects on inflammation or airway remodelling 78 . As miR-126 is highly expressed in the airway wall 77, 78 , but is only present in T cells and other haematopoietic cells at very low levels 26, 31 , it seems probable that the miR-126-specific antagomir affects epithelial cells or other non-haematopoietic cells in the lungs rather than directly affecting infiltrating T H 2 cells in these models. A miR-145-specific antagomir also inhibited allergic airway disease in the HDM mouse model, possibly through effects on smooth muscle cells, which express a large amount of miR-145 (REF. 79 ).
Members of the let-7 family of miRNAs are highly expressed in most cells. miRNAs of the let-7 family directly target IL13 mRNA and decrease IL-13 production by T cells in vitro 80, 81 . However, the intravenous administration of locked nucleic acid (LNA) inhibitors of let-7 ameliorated lung inflammation and airway . miR-146a directly targets Stat1 and the nuclear factor-κΒ (NF-κB) signalling molecules TNF receptor-associated factor 6 (Traf6) and IL-1R-associated kinase 1 (Irak1). TCR activation induces the expression of miR-155, which in turn downregulates the negative regulators of cytokine signalling SH2 domain-containing inositol polyphosphate 5ʹ phosphatase 1 (Ship1) and suppressor of cytokine signalling 1 (Socs1). However, miR-155 has also been proposed to induce the downregulation of Ifngr1. miR-29 limits T H 1 cell differentiation and IFNγ production by targeting the mRNAs encoding T-bet, eomesodermin (Eomes) and IFNγ itself. DC, dendritic cell.
Experimental autoimmune encephalomyelitis
(EAE). An animal model of multiple sclerosis, which is a chronic demyelinating disease in humans. In animals, EAE can be induced by the injection of several different antigens that are derived from the myelin sheath, including myelin basic protein, proteolipid protein or myelin oligodendrocyte glycoprotein, together with a potent adjuvant.
Germinal centres
Specialized anatomical structures in secondary lymphoid organs in which T follicular helper cells provide help to B cells to generate high-affinity antibodies, memory B cells and long-lived plasma cells.
Secondary lymphoid organs
Organized lymphoid structures in which adaptive immune responses are induced; for example, the spleen and the lymph nodes.
hyper-responsiveness in a mouse model of asthma, rather than exacerbating the disease as might have been expected if the dominant effect of let-7 inhibitors was to derepress IL-13 expression in T H 2 cells. let-7 family miRNAs also target IL10 mRNA, and increased IL-10 levels in patients with HIV correlate with decreased expression of let-7 family miRNAs in CD4 + T cells 82 . Taken together, these studies show that individual miRNAs can have a strong effect on type 2 immunity, but also underscore the complexity of miRNA biology in vivo. In particular, they indicate that the targeted delivery of miRNAs or miRNA inhibitors specifically to T cells will be important to manipulate the miRNAmediated control of T H 2 cell gene expression, differentiation and effector functions, whether for scientific or for therapeutic purposes.
T H 17 cell differentiation. T H 17 cells are defined by their expression of the transcription factor retinoic acid receptorrelated orphan receptor-γt (RORγt) and cytokines of the IL-17 family 83 , and they have an important role in the defence against extracellular bacteria and fungi. In addition, they have been implicated in the aetiology and the pathology of several autoimmune diseases including psoriasis, multiple sclerosis, colitis, arthritis and even asthma 84 .
The profiling of miRNAs in T cells from patients with multiple sclerosis, as well as studies in mice and rats with experimental autoimmune encephalomyelitis (EAE; which is a model system for multiple sclerosis), have shown distinct contributions of miRNAs to the regulation of the T H cell subsets involved in this disease 85 . The expression of miR-326 in T H cells correlated with disease severity in mice with EAE and also in patients with multiple sclerosis 86 . miR-326 targets Ets1, which is a negative regulator of T H 17 cell differentiation, leading to increased T H 17 cell differentiation in vitro 86 . Conversely, the expression of miR-10a in CD4 + T cells can limit T H 17 cell differentiation 87 . This effect depends on the presence of retinoic acid, which induces both miR-10a and T-bet expression. The RNA interference-mediated suppression of the miR-10a targets B cell lymphoma 6 (Bcl6) or nuclear receptor co-repressor 1 (Ncor1) limited the differentiation of wild-type T cells, but not of T-bet-deficient T cells, into T H 17 cells. As BCL-6 and NCOR1 modulate the expression and the transcriptional activity of T-bet [88] [89] [90] , and T-bet in turn inhibits the expression of RORγt 91 , miR-10a and T-bet might cooperate to balance T H 1 and T H 17 cell differentiation in retinoic acid-rich microenvironments. In line with these observations, miR-10a overexpression in myelin oligodendrocyte glycoprotein-specific CD4 + T cells delays neurological disease in EAE 87 . miR-155-deficient mice are strongly resistant to EAE. A detailed analysis of these mice showed that miR-155 has a T cell-intrinsic role in T H 17 cell differentiation, as well as an indirect role through regulating the production of T H 17 cell-polarizing cytokines by DCs 55, 92 . The impaired T H 17 cell responses of miR-155-deficient T cells were also observed in a mouse model of Helicobacter pylori infection and in a mouse model of T H 17-driven chronic colitis 56 . Thus, miR-155 promotes T cell-mediated tissue inflammation through the regulation of both T H 1 and T H 17 cell responses. Finally, miR-301a enhances T H 17 cell differentiation, possibly through targeting protein inhibitor of activated STAT3 protein 3 (Pias3), which inhibits STAT3 signalling and T H 17 cell differentiation 93 .
Although the past few years have seen substantial progress in defining the transcriptional requirements for T H 17 cells 94 , studies investigating miRNA function in T H 17 cells remain sparse. Given the high plasticity that is associated with this T H cell subset, it is anticipated that miRNAs will be found to have an important role in defining and maintaining the gene expression programme of differentiated T H 17 cells.
T FH cell differentiation. T FH cells preferentially localize in close proximity to B cells, such as in the germinal centres of secondary lymphoid organs [95] [96] [97] , and they regulate humoral immunity 98 . T FH cells are necessary for effective T cell-dependent antibody responses, such as those induced by common vaccines, and T FH cell dysregulation is involved in several autoimmune diseases 99 . T FH cells express the chemokine receptor CXC-chemokine receptor 5 (CXCR5), the co-inhibitory molecule programmed cell death protein 1 (PD1) and the co-stimulatory molecule inducible T cell co-stimulator (ICOS), and they shape the humoral immune response by providing cytokines that influence immunoglobulin production by B cells 98 . The transcriptional repressor BCL-6 is necessary and sufficient to induce T FH cell differentiation 89, 90, 100 . An initial BCL-6 + CXCR5 + T FH cell population develops directly from naive CD4 + T cells after they are primed by DCs 101, 102 . Subsequent interactions with antigen-specific B cells further polarize T FH cells, promote the formation of germinal centres and contribute to the maintenance of the T FH cell phenotype 100, [103] [104] [105] . Several miRNAs are differentially expressed in T FH cells compared with other T H cell subsets 26 . miRNAs are essential for an early stage in T FH cell differentiation, as activated DGCR8-deficient CD4 + T cells fail to upregulate CXCR5 and downregulate CC-chemokine receptor 7 (CCR7), and this prevents their migration to the T cell-B cell border and into B cell follicles 106 . This defect is in sharp contrast to the role of miRNAs in other T H cell subsets, such as in T H 1 and T H 2 cells, as these cells can still be generated from naive miRNA-deficient CD4 + T cells, even with aberrantly high efficiency in some cases 27, 31 . The fact that T FH cell differentiation strictly requires a transcriptional repressor (BCL-6) and post-transcriptional repressors (miRNAs) indicates that the silencing of alternative differentiation pathways has a crucial role in specifying or maintaining the T FH cell gene expression programme.
So far, only a few studies have provided insights into the roles of individual miRNAs or miRNA families in T FH cells. In sanroque mice, a mutation of the Roquin (also known as Rc3h1) gene, which encodes an RNAbinding protein, leads to excessive T FH cell accumulation, which ultimately causes a lupus-like autoimmune disease 107 . It was initially suggested that Roquin limits T FH cell responses by repressing the 3ʹ UTR of Icos mRNA Processing bodies (P-bodies). Molecular structures in the cytoplasm that are major sites of mRNA turnover.
through a process involving miR-101 binding in processing bodies (P-bodies) 108 . However, subsequent studies clarified that Roquin represses Icos by directly binding to its 3ʹ UTR in an miRNA-independent manner 109 . The miR-17~92 cluster promotes T FH cell differentiation and function independently of its effect on T cell proliferation 106, 110 . miR-17~92 targets Pten in CD4 + T cells 48 and this leads to a small reduction in the number of developing BCL-6 + CXCR5 + T FH cells very early after immunization with model protein antigens 106, 110 . However, other derepressed miR-17~92 target genes probably contribute to the significantly decreased frequency of T FH cells that accumulates later in the response. In this regard, derepression of the miR-17~92 target gene PH domain leucine-rich repeat-containing protein phosphatase 2 (Phlpp2), which is an AKT phosphatase involved in the ICOS-signalling pathway, has been linked to the defective migration of activated miR-17~92-deficient T cells into B cell follicles 110 . A feedback mechanism might limit the expression of miR-17~92 in T FH cells, as Bcl6 transduction decreased miR-17~92 expression in primary T cells and miR-17~92 overexpression reduced CXCR5 expression in B cells 90 . However, the extent to which the reported differences in miRNA expression reflect T cell activation status versus the direct effects of BCL-6 remains unclear.
In a viral infection model, miR-17~92 also prevented the expression of T FH cell-inappropriate genes that are characteristic of T H 17 or T H 22 cells, including Ccr6, Il22 and Rora, which encodes the transcription factor RORα 106 . All four miRNA families present in the miR-17~92 cluster target the Rora mRNA, and aberrant RORα expression is at least partly responsible for the increased expression of CCR6 and IL-22 in miR-17~92-deficient T FH cells 106 . These findings highlight the ability of miRNAs to ensure the fidelity of T H cell subset-specific gene expression programmes. Similarly, miR-10a inhibits the conversion of peripherally derived Further work is needed to comprehensively profile miRNA expression in developing T FH cells and to determine how these miRNAs contribute to the balance between T FH cell and effector T cell differentiation, as well as to the maintenance of T FH cell identity.
Regulation of T Reg cells by miRNAs CD4
+ T Reg cells are essential mediators of peripheral tolerance 115 . They counterbalance the actions of effector T cells, preventing inappropriate or exaggerated immune responses that cause autoimmunity and immunopath ology. Thymus-derived T Reg cells are formed during positive selection in the thymus, but naive CD4 + T cells can also differentiate into peripherally derived T Reg cells 116 . The gene expression programme and the functions of both T Reg cell types depend on the lineage-defining transcription factor forkhead box P3 (FOXP3). Research investigating the requirements for miRNA expression in T Reg cells, as well as the specific contributions of individual miRNAs to T Reg cell development, function and plasticity, has generally outpaced research investigating conventional T cells; however, much remains to be learned.
T Reg cell development and homeostasis are supported by miRNAs, and they are also important for the maintenance of the immunosuppressive function of T Reg cells. Early studies suggested that miRNAs have a predominantly tolerogenic role in T cells, as CD4 + T cells that lack miRNAs fail to develop into T Reg cells in the thymus and have decreased potential to differentiate to in vitroinduced T Reg cells 28 . Moreover, a substantial percentage of mice with miRNA-deficient CD4 + T cells develop spontaneous autoimmunity as they age 28 . Notably, it was recently confirmed that miRNA deficiency in conventional CD4 + T cells is in fact protective against the induction of autoimmunity 29 . By contrast, the conditional deletion of Dicer or Drosha only in FOXP3 + T Reg cells causes an early onset of severe spontaneous autoimmunity 30, 117, 118 . Thus, miRNA expression in T Reg cells is important for the maintenance of self tolerance (FIG. 3a) .
Several miRNAs have been identified that affect T Reg cell development and function (FIG. 3b) . Although T Reg cells and conventional (non-T Reg ) effector CD4 + T cells express a very similar set of miRNAs, expression profiling has shown that several miRNAs are differentially expressed in T Reg cells 25, 26, 28 . miR-155 is highly expressed in T Reg cells, and miR-155-deficient mice have decreased numbers of thymus-derived and peripherally derived T Reg cells 63 . FOXP3 controls this high level of miR-155 expression in T Reg cells and binds to an intronic region of B cell integration cluster (Bic; which is the gene that encodes the primary transcript of miR-155) 63, 119, 120 . miR-155 facilitates T Reg cell homeostasis by targeting Socs1 (REFS 63) , which is a negative regulator of the IL-2 signalling pathway that has a crucial role in T Reg cell development. miR-155 deficiency also reduces IL-2 production by conventional CD4 + T cells 54 , which indicates that this miRNA might regulate IL-2-directed T Reg cell homeostasis through both cell-intrinsic and cell-extrinsic mechanisms.
In addition, miR-146a has a marked effect on T Reg cell function. The restriction of miR-146a deficiency mainly to FOXP3 + T Reg cells using a mixed bone marrow chimaera approach resulted in an IFNγ-dependent and T H 1 cell-mediated pathology 62 , which was similar to the disease observed in mice that had a T Reg cellspecific Dicer or Drosha deficiency 30, 117, 118 . This pathology could be the result of the increased expression of the miR-146a target Stat1 in T Reg cells 62 . However, dysregulated miR-146a-deficient myeloid cells 45 might also contribute to this pathology. Therefore, a T Reg cellintrinsic role for miR-146a in the development of autoimmunity remains to be confirmed using conditional miR-146a-deficient mice. Nature Reviews | Immunology The miR-17~92 cluster represses T Reg cell formation in vitro 64 . miR-17 directly targets transforming growth factor-β receptor II (Tgfbr2) and cAMP-responsive element-binding protein 1 (Creb1), both of which have been implicated in T Reg cell differentiation in vitro 64 . In thymus-derived T Reg cells, miR-17~92 seems to be particularly important during antigenic responses. Although miR-17~92 is dispensable for the development of thymusderived T Reg cells in vivo 64, 121 , miR-17~92 deficiency reduces the number of myelin oligodendrocyte glycoprotein-specific T Reg cells that are peripherally induced during EAE 121 . Similarly, the transgenic overexpression of miR-17~92 does not affect the total number of FOXP3 + T Reg cells in a protein immunization model, but it does increase the frequency of follicular T Reg cells that are generated from thymus-derived T Reg cells 106 . Moreover, T Reg cell-specific miR-17~92 deficiency decreases the frequency of IL-10-producing T Reg cells, which are particularly important for dampening immune responses 121 . Further studies are needed to identify the molecular targets and the roles of miR-17~92 in the regulation of T Reg cell activity. miR-10a is selectively expressed in T Reg cells 26 and it regulates the stability of peripherally derived and in vitro-induced T Reg cells. Retinoic acid functions together with TGFβ to induce miR-10a expression in conventional CD4 + T cells; these conditions also promote the differentiation of peripherally derived T Reg cells 87, 122 . miR-10a is not required for FOXP3 induction in in vitro-induced T Reg cells, but it contributes to T Reg cell stability by maintaining high levels of FOXP3 expression 122 . In addition, miR-10a has been shown to inhibit the conversion of peripherally derived T Reg cells into T FH cells under lymphopenic conditions 87 -a phenomenon originally described for FOXP3 + T Reg cells that had been adoptively transferred to the Peyer's patches of T cell-deficient mice 123 . miR-10a expression in T Reg cells inversely correlates with susceptibility to autoimmune disease: T Reg cells from the autoimmunity-resistant C57BL/6 mouse strain have high levels of miR-10a expression, whereas T Reg cells from the autoimmunity-prone non-obese diabetic (NOD) mouse strain have low levels of miR-10a expression 122 . miR-10a might prevent the inappropriate activation of a T FH cell gene expression programme in T Reg cells by directly targeting the mRNAs that encode the T FH cell lineage-defining transcriptional repressor BCL-6 and its co-repressor NCOR2 (REF. 87 ). As discussed above, miR-10a also limits T H 17 cell differentiation 87 , which adds another layer of complexitiy to the regulatory network that constrains T Reg cell plasticity.
The availability of genetic tools that facilitate the study of T Reg cells in vivo has hastened the pace of research on miRNA function in T Reg cells. miRNAs clearly carry out important functions in regulating the development and the function of T Reg cells. However, further studies are needed to determine the effect of individual miRNAs and their target mRNAs in T Reg cells, and to elucidate their role in the plasticity that is associated with this T H cell subset.
Concluding remarks and future perspectives
It is now generally recognized that miRNAs are important regulators of gene expression in most, if not all, vertebrate cells. The past few years have seen much progress in the field of miRNA-mediated regulation of lymphocyte development and immune function 124 , particularly with respect to T H cells 68, 125, 126 . T H cell differentiation is particularly sensitive to small changes in transcriptional regulation, which is shown by the range . miR-155 promotes T Reg cell maintenance by inhibiting suppressor of cytokine signalling 1 (Socs1), which is a negative regulator of interleukin-2 receptor (IL-2R) signalling. Retinoic acid-induced miR-10a expression suppresses the conversion of T Reg cells into T follicular helper (T FH ) cells under certain conditions by the inhibition of T FH cell-associated transcriptional repressor B cell lymphoma-6 (Bcl6) and the nuclear co-repressor 2 (Ncor2). Although the miR-17~92 cluster has been shown to restrain different aspects of T Reg cell biology, the precise mechanisms by which miR-17~92 regulates these processes remain largely unknown.
of known T H cell subsets and the observed plasticity between some of these differentiated cell types. miRNAs have evolved as a mechanism to fine-tune biological processes 14 , and it is probable that miRNAs represent an equally plastic and adjustable system for the regulation of T H cell differentiation and plasticity.
The complexity and redundancy of miRNA networks underscore the importance of precise gene regulation in the programming of the range of cells that comprise the human body, as well as in the control of their appropriate responses to developmental and environmental cues. This is shown by the observation that defects in single miRNAs within the same cell type can have diverse effects in different experimental contexts, as discussed in this Review for the different T H cell subsets. Most of the progress that has been made regarding miRNA function in T H cells has so far been obtained from in vitro and in vivo mouse models, and relatively little is known about miRNA function in human T H cells. As a way of overcoming this lack of knowledge, it will be interesting to use systems biology approaches, such as exome sequencing, to discover mutations in patients that might correlate with altered miRNA expression. Such tools might also enable screening for alterations in miRNA target sequences that might contribute to the aetiology of immune diseases.
The elucidation of miRNA function in T H cells can be used to increase our understanding of the complex molecular pathways that control the behaviour and cell fate decisions of these cells. Future studies will not only provide insights into the role of miRNAs themselves but also will probably uncover novel mechanisms of immunoregulation through the identification and the functional analysis of miRNA target genes. These studies will ideally identify novel targets for the treatment of conditions in which T H cell functions are impaired or exaggerated. Recent years have seen considerable progress in the field of miRNA-based therapies 127 . The first miRNA-targeted therapy, SPC3649 (miravirsen; Santaris Pharma A/S) -which blocks miR-122 in hepatocytes -reduced the levels of hepatitis C virus RNA in patients who were enrolled in a Phase IIa clinical trial 128 . However, there are serious challenges that need to be overcome before miRNA-targeted therapies can be used in immunological diseases. It will be particularly important to develop enhanced methods for the delivery of these modalities specifically to T H cells in patients 129 . One advantage of the immune system is that many of its effector cells recirculate between sites of inflammation and secondary lymphoid organs via the blood and the lymph fluid. Thus, the systemic delivery of agents that target certain immune cell types might be more easily accomplished than if the agents were delivered to solid organs. Local administration at sites of inflammation might also be sufficient to safely alter immune activation while avoiding the need for cell type-specific targeting. In any case, our increasing knowledge of these tiny but powerful regulators of T H cell function promises new ways to harness and to shape immune responses.
